Prolia Approved for Post-Menopausal Women With Osteoporosis

powered by healthline

Average Ratings

Injectable drug given once every 6 months

WEDNESDAY, June 2 (HealthDay News) -- The injected drug Prolia (denosumab) has been approved by the U.S. Food and Drug Administration to treat post-menopausal women at high risk of bone fracture due to osteoporosis.

Prolia is administered approximately once every six months to increase bone strength and mass, and to prevent bone destruction, the FDA said in a news release.

The drug was evaluated in clinical trials involving more than 7,800 women aged 60 to 91. About 80 percent of people with osteoporosis are women, and about half of women aged 50 or older will sustain an osteoporosis-related fracture at some point in their lives, U.S. government statistics indicate.

Common reported side effects of Prolia include back and extremity pain, high cholesterol, and bladder infection. Severe reactions may include low blood calcium and skin reactions, the agency said.

Because the drug suppresses bone turnover, additional severe reactions could include osteonecrosis of the jaw, a severe bone disease. Prolia will be distributed with a medication guide that explains these and other risks to patients, the FDA said.

Prolia is manufactured by Amgen Inc., based in Thousand Oaks, Calif.

More information

To learn more about this approval, visit the FDA.

-- Scott Roberts
Copyright © 2010 HealthDay. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.